[Rheumatoid arthritis: remission without biotherapy? The experience of Burkina Faso (West Africa)].

Autor:	Ouédraogo A; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Kabore F; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Zabsonré/Tiendrebéogo WJS; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Nonguierma V; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Savadogo B; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Abassiri KAE; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Zongo YE; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso., Damade R; Médecine Hospitalière et Médecine Interne, Centre Hospitalier Louis Pasteur, Chartres, France., Ouédraogo DD; Rhumatologie, Centre Hospitalier et Universitaire de Bogodogo, Ouagadougou, Burkina Faso.
Jazyk:	francouzština
Zdroj:	The Pan African medical journal [Pan Afr Med J] 2024 Jan 10; Vol. 47, pp. 12. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).
DOI:	10.11604/pamj.2024.47.12.37537
Abstrakt:	Introduction: the objective of this study was to evaluate the therapeutic response of patients treated with disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Methods: descriptive and analytical single-center cross-sectional study conducted in Burkina Faso from January 2019 to December 2021 in patients with RA meeting American Rheumatism Association/European League against rheumatism criteria. Therapeutic response was assessed according to the criteria of the European League Against Rheumatism, the clinical disease activity index and the simplified disease activity Index after at least six months of treatment. Results: one hundred and three patients, including 85 women were included. The average age of the patients was 50.14 years ± 15.04 years. Eighty-seven patients (84.47%) were ACPA positive and 50 patients (48.54%) had radiological damage at inclusion. The mean DAS28-CRP, CDAI and SDAI were 5.17, respectively; 32.16 and 35.48 at inclusion compared to 2.53; 7.83 and 8.76 after at least six months of treatment (p<0.0001). Ninety-six patients (93.20%) were treated with methotrexate. According to the criteria of the European League Against Rheumatism, 89 patients (86.41%) were good responders, 62 patients (60.19%) were in remission. Major improvement was observed in 53 patients (51.46%) as assessed by the Clinical Disease Activity Index and the Simplified Disease Activity Index. Conclusion: despite the unavailability of biotherapies in sub-Saharan Africa, remission of RA can be obtained by optimizing treatment with DMARDs and "tight control". Competing Interests: Les auteurs ne déclarent aucun conflit d'intérêts. (Copyright: Aboubakar Ouédraogo et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF